CompletedNot Applicable

Long Term Results and Complications After Epistaxis Treatment

Switzerland591 participantsStarted 2014-01

Plain-language summary

The aim of this study is to find the most agreeable and in the long term most efficient treatment for epistaxis.

Who can participate

Age range14 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: All patients treated during the study period with known address and who did not decease in the meantime. Exclusion Criteria: Insufficiently filled out questionnaires; Obvious lack of ability to remember (as tested by control questions); Known mental disability

What they're measuring

Number of patients without recurrence

Timeframe: Up to 8 years post-treatment

Trial details

NCT IDNCT02127554

SponsorUniversity of Zurich

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2015-12

View on ClinicalTrials.gov More Nosebleed (Epistaxis) - Posterior or Anterior trials